Project Grant R21TW013360
- The National Eye Institute, part of the Department of Health and Human Services National Institutes of Health, awarded $439,174 to the Regents of the University of Minnesota on September 1, 2026, under the Vision Research program (CFDA 93.867) to conduct the first study quantifying how autonomous artificial intelligence diagnostic systems expand access to diabetic retinopathy screening and treatment. The project will use 100% of Medicare claims data to identify adoption of FDA-approved...
- Federal Grant Award Summary Oregon Health & Science University (OHSU) received a $152,379 Project Grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), effective September 1, 2025, through August 31, 2027. The award supports development of an artificial intelligence (AI) framework designed to identify digital biomarkers of glycemic control and...
- The Department of Health and Human Services National Institutes of Health Fogarty International Center awarded the University of Washington $417,681 on August 20, 2026, under the International Research and Research Training program (CFDA 93.989) to develop and evaluate a Systems Analysis and Improvement Approach to optimize cardiometabolic care delivery for hypertension and type 2 diabetes in central Mozambique. The recipient will apply the SAIA implementation strategy to improve diagnosis and...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Updoc AI $1.467 million on September 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop and evaluate the UPDOC Clinical Copilot, an AI agent that directly manages medication prescriptions to improve glycemic control in type 2 diabetes mellitus. The project, titled Titration Response and Enhancement by AI Tools for T2DM (TREAT-T2DM), focuses on optimizing...
- The National Institute of Child Health and Human Development awarded Emory University $426,948 on September 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to develop and validate artificial intelligence models that integrate electronic health record data to identify clinically meaningful subtypes of hypertensive disorders of pregnancy and predict disease onset before clinical diagnosis. The project will model longitudinal physiological changes and...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Delphi Stem, Inc. $306,863 on August 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop a framework for evaluating type 2 diabetes medication efficacy using patient-derived cellular models. The recipient will generate personalized islet-like aggregates from patient cells to predict drug responsiveness and tailor treatment regimens, with the goal of improving...
- The National Institute on Aging awarded The Johns Hopkins University $680,637 on September 15, 2026, under the Aging Research program (CFDA 93.866) to conduct a pragmatic clinical trial improving cognitive impairment screening in older adults with diabetes. The funded work develops and validates novel tools using natural language processing and large language models to identify cognitive impairment and Alzheimer's disease and related dementias screening events in electronic health records. The...
- The National Institute of Biomedical Imaging and Bioengineering awarded the Regents of the University of Minnesota $1,364,828 on April 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to conduct research on safe, effective, and trustworthy artificial intelligence deployment across U.S. healthcare delivery organizations. The project uses mixed methods to identify barriers to and mitigation strategies for AI capability...
- The Department of Health and Human Services National Institutes of Health Fogarty International Center awarded Emory University $201,355 on June 1, 2026, under the International Research and Research Training program (CFDA 93.989) to strengthen HIV-associated non-communicable disease research capacity in Mozambican prisons. Emory will integrate screening for five prioritized non-communicable diseases—smoking, substance use disorders, depression, hypertension, and malnutrition—into mass TB...
- The National Institute on Aging, part of the Department of Health and Human Services National Institutes of Health, awarded The Medical College of Wisconsin, Inc. $195,000 on June 1, 2026, under the Aging Research program (CFDA 93.866) to develop a voice-activated and touchscreen-controlled smart speaker intervention for adults aged 50 and older with poorly controlled type 2 diabetes. The research addresses the disproportionate diabetes burden among older adults, who experience nearly double the...
The Department of Health and Human Services National Institutes of Health Fogarty International Center awarded Emory University $129,531 on September 1, 2026, under the International Research and Research Training program (CFDA 93.989) to develop and validate artificial intelligence software for type 2 diabetes screening integrated into mobile-based fundus imaging. The recipient will develop AI software capable of detecting type 2 diabetes using smartphone-based retinal images collected from approximately 120 people without and with diabetes, then integrate and beta-test the software in a sample of 60 patients. The work includes evaluation of the tool's human-centric usability for healthcare screeners operating the device in hospital settings. This Phase R21 award supports development and feasibility testing; a subsequent R33 phase is anticipated to field-test scalability and effectiveness. The AI module augments existing AI-integrated fundus imaging on mobile phones (Remidio Fundus-on-Phone, FDA-approved for diabetic retinopathy screening) developed through a research-commercial partnership between US and India-based entities. The research team is multidisciplinary, spanning the United States and India, with India selected as a validation site due to high type 2 diabetes prevalence and applicability of screening challenges to rural US populations and low-income countries. Work is performed in Atlanta, Georgia. The period of performance runs through June 30, 2028. This is a project grant, an assistance type supporting research and research training to reduce global health disparities and foster international scientific partnerships.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $129.5k | 8/28/26 |